Literature DB >> 19276666

A one, two punch for liver cancer: anti-angiogenesis with a death receptor agonist.

John P Plastaras1, Kevin R Kozak.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19276666     DOI: 10.4161/cbt.8.5.8261

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  1 in total

1.  Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer.

Authors:  Atil Bisgin; Aysegul Kargi; Arzu D Yalcin; Cigdem Aydin; Deniz Ekinci; Burhan Savas; Salih Sanlioglu
Journal:  BMC Cancer       Date:  2012-02-07       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.